Fibrosis and cirrhosis of liver Clinical Trials
31 clinical trials for Fibrosis and cirrhosis of liver across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Early implantation of a transjugular intrahepatic portosystemic shunt (TIPS) in patients with liver cirrhosis and ascites: a multicentre, randomised controlled trial — RECRUITING
- Impact of an Individualized Prehabilitation Program Combining Nutrition and Exercise on Skeletal Muscle Mass, Nutritional Status, and Quality of Life in Liver Transplant Candidates with Sarcopenia, Frailty, or Malnutrition — RECRUITING
- mplementation of a Multimodal Machine Perfusion Program in Liver Transplantation: A Real-World Analysis of Clinical Outcomes, Logistics, and Resource Use in a European High-Volume Center — RECRUITING
- Predictive factors of persistence of ascites after TIPS implantation — RECRUITING
- RTX001 Autologous Engineered Macrophages for Liver Cirrhosis — RECRUITING · PHASE1
- Stop of proton-pump inhibitor treatment in patients with liver cirrhosis - a double-blind, placebo-controlled trial — RECRUITING
- INFEKTA Register for infectiological complications of cirrhosis and ascites — RECRUITING
- Sarcopenia and sarcopenic obesity assessment in patients with chronic liver disease — RECRUITING
- Role of Bile Acids in the Pathogenesis of Cirrhotic Cardiomyopathy — RECRUITING
- Healing Earth and its role in gastrointestinal diseases: influence of treatment
with Luvos® Heilerde on the intestinal microbiome in healthy individuals, in
patients with irritable bowel syndrome (IBS) and in patients with liver cirrhosis
and concomitant minimal hepatic encephalopathy – the ARENA - Trial — RECRUITING
- Prevalence of antibiotic-resistant enterobacteria in patients with liver cirrhosis — RECRUITING
- Massive ascites: Fractional draining as an alternative to single paracentesis with albumin substitution — RECRUITING
- Non-invasive structure-function assessment of the liver by 2D time-harmonic elastography and the dynamic Liver MAximum capacity (LiMAx) test — RECRUITING
- Prospective study on magnetic resonance tomography (MRI) -based molecular liver parenchyma diagnostics — RECRUITING
- Functional evaluation of donor livers during machine perfusion using indocyanine green (ICG) - for the perspective identification of prognostic factors of transplant function — OTHER
- Expansion of criteria for liver transplants in malignant liver diseases: A policy-oriented analysis within the Eurotransplant network — NOT_YET_RECRUITING
- Drug therapy safety in liver cirrhotic patients through implementation of prescription support — OTHER
- Augmented Reality in Liver Navigation for Laparoscopic Liver Surgery- Trial — OTHER
- Prognostic value of the perioperative platelet function and platelet count in relation to liver regeneration after liver resection — OTHER
- Follow-up examination of cardiac function after liver transplantation using cardiac MRI — OTHER
- Quantitative CT Imaging Parameters for Assessing Hepatic Steatosis in CHB — NOT_YET_RECRUITING
- Randomized controlled clinical study to evaluate a web application (App) to manage and optimize medication — NOT_YET_RECRUITING
- Patient-specific 3D Liver model- based patient information for liver surgery — OTHER
- Comparison of extracorporeal liver support systems MARS and SPAD in a cross over design — OTHER
- High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety — OTHER
- Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites — OTHER
- Value of EUS-guided parenchymal liver biopsy. A randomized controlled trial. — NOT_YET_RECRUITING
- Quantitative MRI Imaging in Diffuse Liver Diseases — OTHER
- TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR) — OTHER · PHASE4
- Stem cells as an alternative therapy to liver transplantation. A combined experimental study and clinical trial. — OTHER
- Prognostic and Diagnostic Relevance of Bacterial DNA Detection in Patients with Liver Cirrhosis and Ascites at Risk for Spontaneous Bacterial Peritonitis (ACTION) - a prospective multicenter Study — OTHER
Refine this search